<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR38">
 <label>38.</label>
 <mixed-citation publication-type="other">Whiffin NA, Irina M; Kleinman, A.; Marshall, J.L.; Minikel, E.V.; Goodrich, J.K.; Quaife, N.; Cole, J.B.; et al. Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsonâ€™s disease. bioRxiv 2019; 10.1101/561472.</mixed-citation>
</ref>
